Inventor
LETAVIC MICHAEL A
US58 patents
⚠️ This page may combine multiple inventors who share the name “LETAVIC MICHAEL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
32 patentsUS10071988B2Sep 11, 2018
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
JANSSEN PHARMACEUTICA NV17 citations93
US9963447B2May 8, 2018
Substituted 4-azaindoles and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV17 citations93
US10150765B2Dec 11, 2018
P2X7 modulators
JANSSEN PHARMACEUTICA NV11 citations92
US10112937B2Oct 30, 2018
P2X7 modulators and methods of use
JANSSEN PHARMACEUTICA NV11 citations92
US9464084B2Oct 11, 2016
P2X7 modulators
JANSSEN PHARMACEUTICA NV16 citations92
US9079911B2Jul 14, 2015
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV13 citations92
US9066946B2Jun 30, 2015
P2X7 modulators
JANSSEN PHARMACEUTICA NV20 citations92
US10617676B2Apr 14, 2020
Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV12 citations85
US9540388B2Jan 10, 2017
P2X7 modulators
JANSSEN PHARMACEUTICA NV5 citations84
US11059828B2Jul 13, 2021
Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV3 citations83
US10377753B2Aug 13, 2019
Substituted 4-azaindoles and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV13 citations83
US10233173B2Mar 19, 2019
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
JANSSEN PHARMACEUTICA NV13 citations83
US11820770B2Nov 21, 2023
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations72
US11667644B2Jun 6, 2023
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
US11225478B2Jan 18, 2022
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations72
US11207298B2Dec 28, 2021
Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
USRE48841EDec 7, 2021
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
US10766880B2Sep 8, 2020
Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
JANSSEN PHARMACEUTICA NV2 citations72
US10703749B2Jul 7, 2020
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations72
US11530210B2Dec 20, 2022
Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators
JANSSEN PHARMACEUTICA NV2 citations68
US11161846B2Nov 2, 2021
Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
JANSSEN PHARMACEUTICA NV2 citations67
US12378254B2Aug 5, 2025
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV0 citations62
US12247027B2Mar 11, 2025
P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations62
US11759455B2Sep 19, 2023
Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
JANSSEN PHARMACEUTICA NV0 citations62
US9096596B2Aug 4, 2015
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations62
US8940731B2Jan 27, 2015
Substituted pyridyl amide compounds as modulators of the histamine H3 receptor
JANSSEN PHARMACEUTICA NV2 citations62
US7687499B2Mar 30, 2010
Cyclopropyl amines as modulators of the histamine H3 receptor
JANSSEN PHARMACEUTICA NV3 citations62
US12338243B2Jun 24, 2025
P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations52
US9321729B2Apr 26, 2016
Substituted pyridyl amide compounds as modulators of the histamine H3 receptor
JANSSEN PHARMACEUTICA NV0 citations52
US9102686B2Aug 11, 2015
5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations52
US10323032B2Jun 18, 2019
P2X7 Modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9604982B2Mar 28, 2017
P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations51
PFIZER
8 patentsUS6696464B2Feb 24, 2004
Triazolo-pyridines anti-inflammatory compounds
PFIZER91 citations97
US7005523B2Feb 28, 2006
Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
PFIZER18 citations92
US6599890B1Jul 29, 2003
Arylsulfonyl hydroxamic acid derivatives
PFIZER22 citations92
US6664395B2Dec 16, 2003
Benzotriazoles anti-inflammatory compounds
PFIZER13 citations83
US7056918B2Jun 6, 2006
Benzimidazole anti-inflammatory compounds
PFIZER10 citations73
US6329397B1Dec 11, 2001
Hydroxy pipecolate hydroxamic acid derivatives
PFIZER8 citations73
US6100240AAug 8, 2000
Macrolide derivatives
PFIZER13 citations69
US7259171B2Aug 21, 2007
Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
PFIZER3 citations62
BRANSTETTER BRYAN JAMES
2 patentsLETAVIC MICHAEL A
2 patentsPFIZER PROD INC
1 patentCHAI WENYING
1 patentKEITH JOHN M
1 patentJansssen Pharmaceutica NV
1 patentDOMBROSKI MARK A
1 patentCARRUTHERS NICHOLAS I
1 patentShowing the top 50 of 58 patents by PatentIndex Score.